A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes

Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3.

Willy A Flegel^{1

2}, Thierry Peyrard³, Jacques Chiaroni^{4

5}, Christophe Tournamille^{6

7}, Déborah Jamet⁸, France Pirenne^{6

7}

¹ Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, United States of America.
² Department of Pathology and Laboratory Medicine, MedStar Georgetown University Hospital, Washington DC, United States of America.
³ Centre National de Référence des Groupes Sanguins, INTS, Paris, France.
⁴ Etablissement Français du Sang, Marseille, France.
⁵ Aix Marseille University, CNRS, ADES, Marseille, France.
⁶ Etablissement Français du Sang Île de France, Créteil, France.
⁷ Institut National de la Santé et de la Recherche Médicale (INSERM)-U955, Equipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale, Créteil, France.
⁸ Etablissement Français du Sang, Brest, France.

No abstract available

Publication types